Incidence of Epstein–Barr virus in Syrian women with breast cancer: A tissue microarray study

References

• Murata T, Tsurumi T. Switching of EBV cycles between latent and lytic states. Rev Med Virol 2014; 24:142-53; PMID:24339346; http://dx.doi.org/10.1002/rmv.1780
   PubMed Web of Science ®Google Scholar
• Münz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol 2008; 18:381-7; PMID:18996483; http://dx.doi.org/10.1016/j.semcancer.2008.10.002
   PubMedGoogle Scholar
• Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 2003; 45:1-36; PMID:12482570; http://dx.doi.org/10.1016/S1040-8428(02)00078-1
   PubMed Web of Science ®Google Scholar
• Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10:803-21; PMID:14871955; http://dx.doi.org/10.1158/1078-0432.CCR-0670-3
   PubMed Web of Science ®Google Scholar
• Amarante MK, Watanabe MA. The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol 2009; 135:329-37; PMID:19009309; http://dx.doi.org/10.1007/s00432-008-0511-2
   PubMed Web of Science ®Google Scholar
• Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 2012; 22:144-53; PMID:22249143; http://dx.doi.org/10.1016/j.semcancer.2012.01.004
   PubMed Web of Science ®Google Scholar
• Morris MA, Dawson CW, Young LS. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 2009; 5:811-25; PMID:19663731; http://dx.doi.org/10.2217/fon.09.53
   PubMed Web of Science ®Google Scholar
• Schlee M, Krug T, Gires O, Zeidler R, Hammerschmidt W, Mailhammer R, Laux G, Sauer G, Lovric J, Bornkamm GW. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV. J Virol 2004; 78:3941-52; PMID:15047810; http://dx.doi.org/10.1128/JVI.78.8.3941-3952.2004
   PubMedGoogle Scholar
• Raab-Traub N. Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2012; 2:453-8; PMID:22858118; http://dx.doi.org/10.1016/j.coviro.2012.07.001
   PubMed Web of Science ®Google Scholar
• He ML, Luo MX, Lin MC, Kung HF. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta 2012; 1825:1-10; PMID:21958739; http://dx.doi.org/10.1016/j.bbcan.2011.09.001
   PubMed Web of Science ®Google Scholar
• Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012; 7:e48788; PMID:23183846; http://dx.doi.org/10.1371/journal.pone.0048788
   PubMed Web of Science ®Google Scholar
• Joshi D, Quadri M, Gangane N, Joshi R, Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One 2009; 4:e8180; PMID:19997605; http://dx.doi.org/10.1371/journal.pone.0008180
   PubMed Web of Science ®Google Scholar
• Lorenzetti MA, De Matteo E, Gass H, Martinez Vazquez P, Lara J, Gonzalez P, Preciado MV, Chabay PA. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One 2010; 5:e13603; PMID:21042577; http://dx.doi.org/10.1371/journal.pone.0013603
   PubMed Web of Science ®Google Scholar
• Xue SA, Lampert IA, Haldane JS, Bridger JE, Griffin BE. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer 2003; 89:113-9; PMID:12838311; http://dx.doi.org/10.1038/sj.bjc.6601027
   PubMed Web of Science ®Google Scholar
• Fawzy S, Sallam M, Awad NM. Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin Biochem 2008; 41:486-92; PMID:18258188; http://dx.doi.org/10.1016/j.clinbiochem.2007.12.017
   PubMed Web of Science ®Google Scholar
• Deshpande CG, Badve S, Kidwai N, Longnecker R. Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 2002; 82:1193-9; PMID:12218080; http://dx.doi.org/10.1097/01.LAB.0000029150.90532.24
   PubMedGoogle Scholar
• Kadivar M, Monabati A, Joulaee A, Hosseini N. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res 2011; 17:489-92; PMID:21207256; http://dx.doi.org/10.1007/s12253-010-9325-z
   PubMedGoogle Scholar
• Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer 2011; 104:332-7; PMID:21179039; http://dx.doi.org/10.1038/sj.bjc.6606048
   PubMedGoogle Scholar
• Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 2008; 99:404-7; PMID:18648363; http://dx.doi.org/10.1038/sj.bjc.6604503
   PubMed Web of Science ®Google Scholar
• Kalkan A, Ozdarendeli A, Bulut Y, Yekeler H, Cobanoglu B, Doymaz MZ. Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues. Med Princ Pract 2005; 14:268-71; PMID:15961939; http://dx.doi.org/10.1159/000085748
   PubMed Web of Science ®Google Scholar
• Zekri AR, Bahnassy AA, Mohamed WS, El-Kassem FA, El-Khalidi SJ, Hafez MM, Hassan ZK. Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women. J Egypt Natl Canc Inst 2012; 24:123-31; PMID:22929918; http://dx.doi.org/10.1016/j.jnci.2012.06.001
   PubMedGoogle Scholar
• Hachana M, Amara K, Ziadi S, Romdhane E, Gacem RB, Trimeche M. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia. Pathol Res Pract 2011; 207:695-700; PMID:22024152; http://dx.doi.org/10.1016/j.prp.2011.09.007
   PubMed Web of Science ®Google Scholar
• Al Moustafa AE, Chen D, Ghabreau L, Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses 2009; 73:184-6; PMID:19361933; http://dx.doi.org/10.1016/j.mehy.2009.02.025
   PubMedGoogle Scholar
• Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010; 6:e1000940; PMID:20532215; http://dx.doi.org/10.1371/journal.ppat.1000940
   PubMed Web of Science ®Google Scholar
• Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y, Pagano JS. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer 2011; 104:1160-7; PMID:21386845; http://dx.doi.org/10.1038/bjc.2011.38
   PubMed Web of Science ®Google Scholar
• Wang L, Tian WD, Xu X, Nie B, Lu J, Liu X, et al. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer 2014; 120:363-72; PMID:24190575; http://dx.doi.org/10.1002/cncr.28418
   PubMed Web of Science ®Google Scholar
• Al Moustafa AE, Achkhar A, Yasmeen A. EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed) 2012; 4:671-84; PMID:22202084; http://dx.doi.org/10.2741/S292
   PubMedGoogle Scholar
• QingLing Z, LiNa Y, Li L, Shuang W, YuFang Y, Yi D, Divakaran J, Xin L, YanQing D. LMP1 antagonizes WNT/β-catenin signalling through inhibition of WTX and promotes nasopharyngeal dysplasia but not tumourigenesis in LMP1(B95-8) transgenic mice. J Pathol 2011; 223:574-83; PMID:21394719; http://dx.doi.org/10.1002/path.2820
   PubMedGoogle Scholar